| Date | Form | Description | Docs | XBRL | Pages |
| 03/13/08 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/12/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
76 | |
| 03/12/08 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 03/05/08 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 02/20/08 | UPLOAD | SEC-generated letter |
|
3 | |
| 01/15/08 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
57 | |
| 01/15/08 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 12/27/07 | 8-K | Current report filing |
|
13 | |
| 12/18/07 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/15/07 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...